Benzinga's Top Ratings Upgrades, Downgrades For August 23, 2022

 

Upgrades

  • Wedbush upgraded the previous rating for Denny's Corp DENN from Neutral to Outperform. For the second quarter, Denny's had an EPS of $0.11, compared to year-ago quarter EPS of $0.18. The current stock performance of Denny's shows a 52-week-high of $16.97 and a 52-week-low of $8.46. Moreover, at the end of the last trading period, the closing price was at $9.38.

See all analyst ratings upgrades.

 

Downgrades

  • For Aerie Pharmaceuticals Inc AERI, Stifel downgraded the previous rating of Buy to Hold. Aerie Pharmaceuticals earned $0.32 in the second quarter, compared to $0.84 in the year-ago quarter. The current stock performance of Aerie Pharmaceuticals shows a 52-week-high of $11.83 and a 52-week-low of $4.81. Moreover, at the end of the last trading period, the closing price was at $11.15.
  • For Allarity Therapeutics Inc ALLR, Ladenburg Thalmann downgraded the previous rating of Buy to Neutral. For the first quarter, Allarity Therapeutics had an EPS of $0.56, compared to year-ago quarter EPS of $0.68. At the moment, the stock has a 52-week-high of $12.86 and a 52-week-low of $1.06. Allarity Therapeutics closed at $1.52 at the end of the last trading period.
  • For Zoom Video Communications Inc ZM, BTIG downgraded the previous rating of Buy to Neutral. For the second quarter, Zoom Video Comms had an EPS of $1.05, compared to year-ago quarter EPS of $1.36. At the moment, the stock has a 52-week-high of $184.91 and a 52-week-low of $79.03. Zoom Video Comms closed at $97.44 at the end of the last trading period.
  • According to Morgan Stanley, the prior rating for Grocery Outlet Holding Corp GO was changed from Equal-Weight to Underweight. For the second quarter, Grocery Outlet Holding had an EPS of $0.29, compared to year-ago quarter EPS of $0.23. The stock has a 52-week-high of $46.37 and a 52-week-low of $23.69. At the end of the last trading period, Grocery Outlet Holding closed at $41.74.
  • According to Morgan Stanley, the prior rating for Pharvaris NV PHVS was changed from Overweight to Equal-Weight. In the first quarter, Pharvaris showed an EPS of $0.54, compared to $0.80 from the year-ago quarter. At the moment, the stock has a 52-week-high of $27.50 and a 52-week-low of $11.06. Pharvaris closed at $12.14 at the end of the last trading period.
  • For ZIM Integrated Shipping Services Ltd ZIM, Citigroup downgraded the previous rating of Buy to Neutral. ZIM Integrated Shipping earned $11.07 in the second quarter, compared to $7.38 in the year-ago quarter. The stock has a 52-week-high of $91.23 and a 52-week-low of $40.67. At the end of the last trading period, ZIM Integrated Shipping closed at $50.92.
  • Ascendiant Capital downgraded the previous rating for AutoWeb Inc AUTO from Buy to Hold. AutoWeb earned $0.33 in the second quarter, compared to $0.02 in the year-ago quarter. The stock has a 52-week-high of $4.35 and a 52-week-low of $0.29. At the end of the last trading period, AutoWeb closed at $0.39.
  • Needham downgraded the previous rating for Clarus Therapeutics Holdings Inc CRXT from Buy to Hold. For the second quarter, Clarus Therapeutics Hldgs had an EPS of $0.21, compared to year-ago quarter EPS of $0.00. At the moment, the stock has a 52-week-high of $3.94 and a 52-week-low of $0.17. Clarus Therapeutics Hldgs closed at $0.19 at the end of the last trading period.
  • For Aerie Pharmaceuticals Inc AERI, Cantor Fitzgerald downgraded the previous rating of Overweight to Neutral. For the second quarter, Aerie Pharmaceuticals had an EPS of $0.32, compared to year-ago quarter EPS of $0.84. The current stock performance of Aerie Pharmaceuticals shows a 52-week-high of $11.83 and a 52-week-low of $4.81. Moreover, at the end of the last trading period, the closing price was at $11.15.

See all analyst ratings downgrades.

 

Initiations

  • With an Outperform rating, Macquarie initiated coverage on Baidu Inc BIDU. The price target seems to have been set at $188.00 for Baidu. For the first quarter, Baidu had an EPS of $1.77, compared to year-ago quarter EPS of $1.89. At the moment, the stock has a 52-week-high of $171.87 and a 52-week-low of $101.62. Baidu closed at $131.46 at the end of the last trading period.
  • Macquarie initiated coverage on iQIYI Inc IQ with an Underperform rating. The price target for iQIYI is set to $2.80. iQIYI earned $0.03 in the first quarter, compared to $0.25 in the year-ago quarter. The current stock performance of iQIYI shows a 52-week-high of $5.77 and a 52-week-low of $1.86. Moreover, at the end of the last trading period, the closing price was at $3.62.
  • With a Buy rating, Roth Capital initiated coverage on Helius Medical Technologies Inc HSDT. The price target seems to have been set at $5.00 for Helius Medical Tech. In the second quarter, Helius Medical Tech showed an EPS of $0.97, compared to $2.58 from the year-ago quarter. The current stock performance of Helius Medical Tech shows a 52-week-high of $5.79 and a 52-week-low of $0.45. Moreover, at the end of the last trading period, the closing price was at $0.55.
  • Argus Research initiated coverage on AutoNation Inc AN with a Buy rating. The price target for AutoNation is set to $150.00. For the second quarter, AutoNation had an EPS of $6.48, compared to year-ago quarter EPS of $4.83. The current stock performance of AutoNation shows a 52-week-high of $135.57 and a 52-week-low of $96.56. Moreover, at the end of the last trading period, the closing price was at $124.42.
  • B of A Securities initiated coverage on PLAYSTUDIOS Inc MYPS with an Underperform rating. The price target for PLAYSTUDIOS is set to $3.00. In the second quarter, PLAYSTUDIOS showed an EPS of $0.04, compared to $0.07 from the year-ago quarter. The current stock performance of PLAYSTUDIOS shows a 52-week-high of $6.60 and a 52-week-low of $3.49. Moreover, at the end of the last trading period, the closing price was at $3.97.
  • Mizuho initiated coverage on Ocugen Inc OCGN with a Buy rating. The price target for Ocugen is set to $5.00. Ocugen earned $0.09 in the second quarter, compared to $0.13 in the year-ago quarter. The stock has a 52-week-high of $4.90 and a 52-week-low of $1.67. At the end of the last trading period, Ocugen closed at $2.34.

See all analyst ratings initiations.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsBZI-Ratings
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!